Recent Advances in Aptamers Targeting Immune System

被引:13
|
作者
Hu, Piao-Ping [1 ,2 ]
机构
[1] Nanchang Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 1, Dept Blood Transfus, Nanchang 330006, Jiangxi, Peoples R China
关键词
aptamer; immune system; inflammation; therapy; RNA APTAMER; HIGH-AFFINITY; DNA APTAMERS; INTERLEUKIN-6; RECEPTOR; INNATE IMMUNITY; TNF-ALPHA; CELLS; LIGANDS; MOLECULES; SELECTION;
D O I
10.1007/s10753-016-0437-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The immune system plays important role in protecting the organism by recognizing non-self molecules from pathogen such as bacteria, parasitic worms, and viruses. When the balance of the host defense system is disturbed, immunodeficiency, autoimmunity, and inflammation occur. Nucleic acid aptamers are short single-stranded DNA (ssDNA) or RNA ligands that interact with complementary molecules with high specificity and affinity. Aptamers that target the molecules involved in immune system to modulate their function have great potential to be explored as new diagnostic and therapeutic agents for immune disorders. This review summarizes recent advances in the development of aptamers targeting immune system. The selection of aptamers with superior chemical and biological characteristics will facilitate their application in the diagnosis and treatment of immune disorders.
引用
收藏
页码:295 / 302
页数:8
相关论文
共 50 条
  • [31] Selection of aptamers targeting small molecules by capillary electrophoresis: Advances, challenges, and prospects
    Hu, Yangyang
    Jiang, Guangyu
    Wen, Yalun
    Shao, Yuchen
    Yang, Ge
    Qu, Feng
    BIOTECHNOLOGY ADVANCES, 2025, 78
  • [32] Recent Advances in Chronotherapy Targeting Respiratory Diseases
    Paudel, Keshav Raj
    Jha, Saurav Kumar
    Allam, Venkata Sita Rama Raju
    Prasher, Parteek
    Gupta, Piyush Kumar
    Bhattacharjee, Rahul
    Jha, Niraj Kumar
    Vishwas, Sukriti
    Singh, Sachin K.
    Shrestha, Jesus
    Imran, Mohammad
    Panth, Nisha
    Chellappan, Dinesh Kumar
    Ebrahimi Warkiani, Majid
    Hansbro, Philip M.
    Dua, Kamal
    PHARMACEUTICS, 2021, 13 (12)
  • [33] RECENT ADVANCES IN PEPTIDE RECEPTOR TARGETING OF CANCER
    Reubi, Jean Claude
    NEUROPEPTIDES, 2010, 44 (06) : 527 - 527
  • [34] Recent advances on FXR-targeting therapeutics
    Panzitt, Katrin
    Zollner, Gernot
    Marschall, Hanns-Ulrich
    Wagner, Martin
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2022, 552
  • [35] Targeting cancer with lactoferrin nanoparticles: recent advances
    Kondapi, Anand K.
    NANOMEDICINE, 2020, 15 (21) : 2071 - 2083
  • [36] Recent advances in chemistry related to antibody targeting
    Meares, C.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (04) : 513 - 513
  • [37] Recent advances in drug delivery and targeting to the brain
    Sethi, Bharti
    Kumar, Virender
    Mahato, Kalika
    Coulter, Donald W.
    Mahato, Ram I.
    JOURNAL OF CONTROLLED RELEASE, 2022, 350 : 668 - 687
  • [38] Recent Advances in Claudin-Targeting Technology
    Nagase, Shotaro
    Doyama, Ryo
    Yagi, Kiyohito
    Kondoh, Masuo
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2013, 36 (05) : 708 - 714
  • [39] Recent advances in therapeutic targeting of inflammation in atherosclerosis
    Hedin, Ulf
    Matic, Ljubica Perisic
    JOURNAL OF VASCULAR SURGERY, 2019, 69 (03) : 944 - 951
  • [40] Recent Advances on Targeting Proteases for Antiviral Development
    Borges, Pedro Henrique Oliveira
    Ferreira, Sabrina Baptista
    Silva Jr, Floriano Paes
    VIRUSES-BASEL, 2024, 16 (03):